# Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

Study · id `cardio:ct-nct01348074` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01348074](<https://clinicaltrials.gov/study/NCT01348074>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01348074

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT01348074. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT01348074, source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01348074, source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01348074, source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01348074, source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01348074, source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01348074-2016-04-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
- Acronym: DOSIDO
- Condition: Atrial Fibrillation
- Condition: Venous Thromboembolism
- Condition: Heart Valve Disease
- Condition: Surgery
- Intervention (Drug): Double dose
- Lead sponsor: McMaster University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: McMaster University (`cardio:org-mcmaster-university`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial (`cardio:pubmed-24837794`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fd0c3289f8e44ecd5c5651a23bfb2b8a5d8f3f39c0e2d6129eaa95c9f040e17f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
